Top news of the week: 25.05.2022.
Companies And Industries
Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
Read the latest news about our company
Union Minister Dr Jitendra Singh launches Single National Portal for Biotech researchers and Start-Ups;
In keeping with the spirit of "One Nation,One Portal", Union Minister of State (IC) Ministry of Scie
Biopharma consultant charged with insider trading
An executive compensation consultant is facing both civil and criminal charges related to insider trading in advance of an acquisition announcement by one of his clients, Kadmon Holding Inc.
Biopharma grant and nonprofit deal values plunge
As the COVID-19 pandemic continues to wind down, the value of biopharma company deals with nonprofit and government entities, as well as grants, are down nearly 64%. Through mid-May 2022, ...
Vir Biotech, Wuxi Biologics End COVID-19 Antibody Collaboration
Vir Biotechnology terminated a two-year-old COVID-19-related antibody collaboration with Wuxi Biologics that included sotrovimab, which lost EUA in the U.S. earlier this year.
Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry
Immunoglobulins type-M (IgMs) are one of the first antibody classes mobilized during immune responses against pathogens and tumor cells. Binding to specific target antigens enables the ...
Top 5 takeaways from international hybrid and virtual meeting guidance for pharma
The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint guidance, from the IFPMA, EFPIA, and PhRMA, provides clarity.
Cancer-killing bacteria evade the immune system
A “cloaking” system controls the delivery of engineered bacteria for cancer therapy